

> 定義


# SYNCOPE

### 定義

• Symptom of sudden transient loss of consciousness due to global cerebral hypoperfusion

• If CPR or cardioversion required, then SCD and not syncope (different prognosis)

• Presyncope = prodrome of light-headedness withoutut LOC

### 原因 (_JACC_ 2017;70:e39; _EHJ_ 2018;39:1883)

• **Neurocardiogenic** (a.k.a. vasovagal, ~25%): ↑ sympathetic tone → vigorous contraction of LV → LV mechanoreceptors trigger ↑ vagal tone (hyperactive Bezold-Jarisch reflex) → ↓ HR (cardioinhib.) and/or ↓ BP (vasodepressor). Cough, deglutition, defecation, & micturition → ↑ vagal tone and thus can be precipitants. Carotid sinus hypersensitivity (exag vagal resp to carotid massage) is related disorder.

• **Orthostatic hypotension** (~10%)

hypovolemia/diuretics, deconditioning; vasodilat. (esp. if combined with ⊖ chronotropes)

autonomic neuropathy \[1° = Parkinson’s, MSA/Shy-Drager, Lewy body dementia, POTS (dysautonomia in the young); 2° = DM, EtOH, amyloidosis, CKD\] (_NEJM_ 2008;358:615)

• **Cardiovascular** (~20%, more likely in men than women)

_Arrhythmia_ (~15%): challenging to dx because often transient

Bradyarrhythmias: SB, SSS, high-grade AV block, ⊖ chronotropes, PPM malfunction

Tachyarrhythmias: VT, SVT (syncope rare unless structural heart disease or WPW)

_Mechanical_ (5%)

Endocardial/Valvular: critical AS, MS, PS, prosthetic valve thrombosis, myxoma

Myocardial: outflow obstruction from HCMP (or VT); Pericardial: tamponade

Vascular: PE (in ~25% without alt dx; _NEJM_ 2016;375:1524), PHT, AoD, ruptured AAA

• **Neurologic** (~10%): vertebrobasil insuff, cerebrovasc dissection, SAH, TIA/CVA, migraine

• Misc. causes of LOC (but not syncope): seizure, ↓ glc, hypoxia, narcolepsy, psychogenic

### Workup (etiology cannot be determined in ~40% of cases) (_jama_ 2019;321:2448)

• _H&P incl. orthostatic VS have highest yield and most cost effective_ (_Archives_ 2009;169:1299)

• _排除 life-threatening dx including: cardiac syncope, severe blood loss, PE, SAH_

• **History** (from Pt and _witnesses_ if available)

activity and posture before the incident

precipitating factors: exertion (AS, HCMP, PHT), positional ∆ (orthostatic HoTN), stressors such as sight of blood, pain, emotional distress, fatigue, prolonged standing, warm environment, N/V, cough/deglutition/micturition/defecation (neurocardiogenic), head turning or shaving (carotid sinus hypersens.); arm exercise (subclavian steal)

sudden onset → cardiac; prodrome (eg, diaphoresis, nausea, blurry vision) → vasovagal

associated sx: chest pain, palp., neurologic, postictal, bowel/bladder incontinence, (convulsive activity for <10 sec may occur with transient cerebral HoTN & mimic seizure)

• **PMH:** prior syncope, previous cardiac or neurologic dis.; no CV disease at baseline → 5% cardiac, 25% vasovagal; CV disease → 20% cardiac, 10% vasovagal (_NEJM_ 2002;347:878)

• **Medications that may act as precipitants**

vasodilators: α-blockers, nitrates, ACEI/ARB, CCB, hydralazine, phenothiazines, antidep.

diuretics; ⊖ chronotropes (eg, βB and CCB)

proarrhythmic or QT prolonging: class IA, IC or III antiarrhythmics (see “ECG”)

psychoactive drugs: antipsychotics, TCA, barbiturates, benzodiazepines, EtOH

• **Family history:** CMP, SCD, syncope (vasovagal may have genetic component)

• **Physical exam**

### VS incl. _orthostatics_ (⊕ if supine → standing results in ≥20 mmHg ↓ SBP or ≥10 ↓ DBP or SBP <90 mmHg within 3 min; POTS if ≥30 bpm ↑ HR within 10 min), BP in both arms

Cardiac: HF (↑ JVP, displ. PMI, S3), murmurs, LVH (S4, LV heave), PHT (RV heave, ↑ P2)

Vascular: ✔ for _asymmetric pulses_, carotid/vert/subclavian _bruits; carotid sinus massage_ to ✔ for carotid hypersens (if no bruits): ⊕ if asystole >3 sec or ↓ SBP >50 mmHg

Neurologic exam: focal findings, evidence of tongue biting; FOBT

• **ECG** (abnormal in ~50%, but only definitively identifies cause of syncope in <10%)

Conduction: SB, sinus pauses/sinus arrhythmia, AVB, BBB/IVCD

Arrhythmia: ectopy, ↑ or ↓ QT, preexcitation (WPW), Brugada, ε wave (ARVC), SVT/VT

Ischemic changes (new or old): atrial or ventricular hypertrophy

• Lab: glc, Hb, HCG (pre-menop ♀), ? D\-dimer, ? troponin/NT-proBNP (↓ yield without other signs and symptoms)

### Other diagnostic studies (consider based on results of H&P and ECG)

• Ambulatory ECG monitoring: if suspect arrhythmogenic syncope

Holter monitoring (continuous ECG 24–72 h): useful if _frequent_ events arrhythmia + sx (4%); asx but signif. arrhythmia (13%); sx but no arrhythmia (17%)

Event recorder (activated by Pt to record rhythm strip): limited role in syncope because only useful if established prodrome (because must be Pt activated)

External loop recorders (continuously saves rhythm, ∴ can be activated _after_ an event): useful for episodes (including without prodrome) likely to occur within 1 mo; can be coupled with mobile cardiac telemetry than can be auto-triggered for specific rhythms

_Implantable_ loop recorders (SC; can record 2–3 y; can be triggered): useful if episodes <1/mo; dx in 55% of cases; rec for recurrent syncope without prodrome

• Echo: consider to 排除 structural heart disease (eg, CMP \[incl HCMP & ARVC\], valvular disease \[incl AS, MS, MVP\], myxoma, amyloid, PHT, ± anomalous coronaries)

• ETT/CCTA/Cath: esp. with exertional syncope; 排除 ischemia or catechol-induced arrhythmia

• Electrophysiologic studies (EPS): consider in high-risk 病人 in whom tachy or brady etiology is strongly suspected (eg, prior MI), but cannot be confirmed; avoid if ECG/Echo normal.

50% 異常 (inducible VT, conduction abnormalities) if heart disease, but ? significance

3–20% 異常 if 異常 ECG; <1% 異常 if normal heart and normal ECG

• Tilt table: debated utility due to poor Se/Sp/reproducibility; consider if suspected neurocardiogenic, orthostatic HoTN, POTS, or psychogenic, and initial eval unrevealing

• Cardiac MRI: helpful to dx sarcoid or ARVC if suggestive ECG, echo (RV dysfxn) or ⊕ FHx

• Neurologic studies (cerebrovascular studies, CT, MRI, EEG): if H&P suggestive; low yield

### Figure 1-6 Approach to syncope

![](https://i.imgur.com/3T0lyoS.jpg)

(_Adapted from JACC_ 2017;70:e39)

### High-risk features (admit with tele; _JACC_ 2017;70:620; _EHJ_ 2018;39:1883)

• Age >60 y, h/o CAD, HF/CMP, valvular or congenital heart dis., arrhythmias, FHx SCD

• Syncope c/w cardiac cause (lack of prodrome, exertional, resultant trauma) or recurrent

• Complaint of chest pain or dyspnea; 異常 VS, cardiac, pulm, or neuro exam; low Hct

• ECG suggesting conduction abnormality, arrhythmia, or ischemia; Pt with PPM/ICD

• Canadian Syncope Risk Score (_CMAJ_ 2016;188:e289) stratifies from <1% to >20% risk of serious arrhythmias. If low-risk & no arrhythmia in ED × 2 h, 0.2% risk over 30 d.

### 治療 (_EHJ_ 2018;39:1883)

• Arrhythmia, cardiac mechanical or neurologic syncope: treat underlying disorder, ? ICD if Brugada pattern, sarcoid, ARVC, early repol + syncope

• Neurocardiogenic: consider fludrocortisone or midodrine (_JACC_ 2016;68:1; _Neuro_ 2014;83:1170); ? βB or SSRI (_Circ A&E_ 2012; 5:920)

consider dual-chamber PPM if rec episodes + prolonged pauses (_Circ_ 2012;125:2566)

• Orthostatic: 2–3 L fluid & 10 g Na per day; rise from supine to standing _slowly_, compression stockings; consider midodrine or fludrocortisone; ? atomoxetine (_HTN_ 2014;64:1235)

### Prognosis (_Ann Emerg Med_ 1997;29:459; _NEJM_ 2002;347:878)

• 22% overall recurrence rate if idiopathic, else 3% recurrence

• Cardiac syncope has poor prognosis (20–40% 1-y SCD rate); vasovagal good prognosis

• Unexplained syncope with 1.3-fold ↑ in mort., but noncardiac or unexplained syncope with 正常

ECG, no h/o VT, no HF, age <45 → low recurrence rate and <5% 1-y SCD rate

• ✔ state driving laws and MD reporting requirements. Consider appropriateness of Pt involvement in exercise/sport, operating machinery, high-risk occupation (eg, pilot).
